Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Days Sales Outstanding : 65.34 (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Days Sales Outstanding?

Shanghai Fosun Pharmaceutical (Group) Co's average Accounts Receivable for the three months ended in Dec. 2023 was HK$8,379 Mil. Shanghai Fosun Pharmaceutical (Group) Co's Revenue for the three months ended in Dec. 2023 was HK$11,703 Mil. Hence, Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 65.34.

The historical rank and industry rank for Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding or its related term are showing as below:

HKSE:02196' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.46 Med: 50.67 Max: 70.11
Current: 70.11

During the past 13 years, Shanghai Fosun Pharmaceutical (Group) Co's highest Days Sales Outstanding was 70.11. The lowest was 42.46. And the median was 50.67.

HKSE:02196's Days Sales Outstanding is ranked better than
51.65% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 71.68 vs HKSE:02196: 70.11

Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding increased from Dec. 2022 (54.96) to Dec. 2023 (65.34).

Shanghai Fosun Pharmaceutical (Group) Co Days Sales Outstanding Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Days Sales Outstanding Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

51.50

52.17

48.88

58.96

67.85

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															54.96	64.09	73.80	82.72	65.34

Competitive Comparison of Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding falls into.

Shanghai Fosun Pharmaceutical (Group) Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (8473.742	+	8360.557)	/	2 )	/	45281.943	*	365
=	8417.1495					/	45281.943	*	365
=	67.85

Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (8397.888	+	8360.557)	/	2 )	/	11702.801	*	365 / 4
=	8379.2225					/	11702.801	*	365 / 4
=	65.34

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Shanghai Fosun Pharmaceutical (Group) Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

SFOSF:USA 08HH:Germany 600196:China

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Headlines

No Headlines